SEC 13F Intelligence

Foresite Capital Management Vi LLC / ALLO

Foresite Capital Management Vi LLC’s Allogene Therapeutics Inc Position

Does Foresite Capital Management Vi LLC own Allogene Therapeutics Inc (ALLO)? Not currently — the last reported position was 2.88M shares worth $3M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q2 2025
Shares
2.88M
% of Portfolio
+1.83%
Quarters Held
3
position exited

Position History ALLO

Reported value by quarter
Q4 ’24: $7MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $3MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20252.88M$3M+1.83%
Q1 20253.45M$5M+2.76%
Q4 20243.45M$7M+3.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of ALLO.